ZAP-X

San Carlos, United States Founded: 2014 • Age: 12 yrs
Developer of gyroscopic radiosurgery platform

About ZAP-X

ZAP-X is a Healthcare company based in San Carlos (United States) founded in 2014. ZAP-X has raised $195 million across 3 funding rounds from investors including Foxconn Electronics, Varian and Chow Tai Fook Jewellery. The company has 1 employees. Its website zapsurgical.com draws about 10 thousand monthly visits. Its Indian entity Zap Surgical India Private Limited reported revenue of ₹3.17 Cr. Its focus areas include Life Sciences, Oncology, Medical Devices and Therapies. Its competitors include RefleXion and Mevion Medical Systems; 2 of its 2 listed competitors have raised funding.

Company details

Developer of gyroscopic radiosurgery platform. The companys flagship product, ZAP-X platform is a self-shielding technology and non-invasive cancer radiotherapy treatment device. It has applications for the treatment of brain and head and neck cancers.

Key Metrics
  • Indian entity revenue
    ₹3.17 Cr

    FY 2025 · +44% YoY

  • Indian entity net profit
    ₹25.4 Lakh

    FY 2025 · 8% margin

  • Indian entity EBITDA
    ₹34.1 Lakh

    FY 2025 · 11% margin

  • Total Equity Funding
    $195M (USD)

    in 3 rounds

  • Latest Funding Round
    $36M (USD), Series E

    Oct 2026

  • Investors
  • Employee Count
    1

Apps and channels of ZAP-X

its YouTube channel ZAP Surgical has 1.81K subscribers and 22 videos.

ZAP Surgical
YouTube 1.81K subscribers 22 videos Science & Technology
Open channel

Videos from ZAP-X

The most watched videos on ZAP-X's YouTube channel, ZAP Surgical (1.81K subscribers). Click a video to play it here.

ZAP-X®. First-In-Kind. Vault-Free. Cobalt-Free.
63.9K views
ZAP-X: Gyroscopic Radiosurgery. Purpose-built for SRS.
22.9K views
ZAP-X® Gyroscopic Radiosurgery™ Platform
16.1K views
Time-lapse ZAP-X installation at St. Bonifatius Hospital, Lingen, Germany
13.9K views

More on ZAP Surgical.

Funding Insights of ZAP-X

ZAP-X has successfully raised a total of $195M across 3 strategic funding rounds. The most recent funding activity was a Series E round of $36 million completed in October 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $195M
  • Total Rounds 3
  • Last Round Series E — $36M
  • First Round $81M

    (Jan 2020)

  • Investors Count 9

All 3 funding rounds of ZAP-X with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2026$36MSeries E–Catalio Capital Management
–
Nov 2024$78MSeries E––
Jan 2020$81MSeries D–Primavera
Valuation history

9 investors in total: 9 institutional.

Investors in ZAP-X

ZAP-X has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Foxconn Electronics, Varian and Chow Tai Fook Jewellery.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Private equity investments in China are managed by Primavera.
2010primavera-capital.comBeijing, China
PE firm investing in Asia
gthcap.comHong Kong, China
shangbaycapital.com
cataliocapital.com
baheal.cn
Jewellery manufacturing company
1929chowtaifook.comHong Kong, China
Tailored crop insurance solutions are provided for farmers and agents.
1961hogy.co.jpMinato City, Japan
Varian is focused on developing cancer treatment technologies.
1948varian.comPalo Alto, United States
Electronic products and components are manufactured globally by Foxconn.
1974foxconn.comTaipei, Taiwan
Premium access

Investor details for ZAP-X

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Zap Surgical India Private Limited (ZAP-X)

Zap Surgical India Private Limited is the primary company behind ZAP-X. The board of Zap Surgical India Private Limited currently have 2 directors; the longest-serving is Saloni Singh, appointed in 2022.

DirectorDesignationAppointedTenureEntity
Saloni Singh
DIN 06883526
Director30 Aug 20224 yrs 2 moZap Surgical India Private Limited
John Rodenbeck Adler Jr
DIN 09721333
Director30 Aug 20224 yrs 2 moZap Surgical India Private Limited

People of ZAP-X

24 people are tracked at ZAP-X (14 in leadership, 10 in team); the tracked headcount is 1.

NameRoleGroup
Mike Enock
VP OperationsLeadership
Alison Biondi Khalaf
Director Customer OperationsLeadership
Soohun KYUNG
Country Head, KoreaLeadership
Mark Arnold
Executive Vice President, MarketingLeadership
Michael Natale CPA, CFP, MBA
Vice President of FinanceLeadership
Derek DeScioli
Chief Operating OfficerLeadership
CEOLeadership
Ron Ronquillo
Sr. Director, Service and SupportLeadership
Sebastian Adamczyk
Senior Director Of Clinical OperationsLeadership
Alex Maslowski, PhD
Vice President SoftwareLeadership
Christopher Brown
Vice President Regulatory Affairs Quality AssuranceLeadership
Ashley Wiley Braswell
Director, Marketing CommunicationsLeadership
Jinhua Yang
President Zap ChinaLeadership
Stephanie Key
Commercial Clinical DirectorLeadership
Maria S.
Medical Physicist | Global Clinical OperationsTeam
Frank Xian
Senior Manager Clinical Operations APACTeam
Brandon Frederick
Principal Software EngineerTeam
Georg Weidlich
Medical Physicist and Radiation Safety OfficerTeam
Nitya Chinchani
Manager, Software Data ManagementTeam
George Wu
Corporate ControllerTeam

4 more people are available in the full profile.

Premium access

Complete people profiles for ZAP-X

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of ZAP-X

Figures of Zap Surgical India Private Limited, the primary company behind ZAP-X, for FY 2025. Revenue was ₹3.17 Cr (+44% year on year). Net profit was ₹25.4 Lakh (8% margin). EBITDA was ₹34.1 Lakh (11% margin).

  • ₹3.17 CrRevenue · FY 2025 · +44% YoY
  • ₹25.4 LakhNet profit · 8% margin
  • ₹34.1 LakhEBITDA · 11% margin
  • ₹10 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Zap Surgical India Private Limited are on its company page.

Premium access

Detailed financial statements for ZAP-X

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of ZAP-X

3 dated milestones of ZAP-X across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded ZAP-X is founded.
  2. Funding First funding round of $81.0M.
  3. Funding Latest funding round, Series E, of $36.0M.

Competitors of ZAP-X

ZAP-X has 2 listed competitors in our database, 2 of them funded. They include RefleXion and Mevion Medical Systems.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
reflexion.com2009Hayward, United States$553.91M257
Biology-guided radiotherapy systems are provided for cancer treatment.
mevion.com2004Littleton, United States$500.18M136
Proton therapy systems are supplied for cancer radiation treatment.
Premium access

Detailed competitors of ZAP-X

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of ZAP-X

The website of ZAP-X (zapsurgical.com) receives about 10.3K visits a month.

  • Monthly visits
    10.3K

    ▲ 37.2% vs previous month

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as ZAP-X (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Zap-X

Premium access

Complete news archive for ZAP-X

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ZAP-X

ZAP-X was founded in 2014 and raised its 1st funding round 6 years after it was founded.

ZAP-X is headquartered in San Carlos, United States. It is registered at San Carlos, California, United States.

ZAP-X is a funded company, having raised a total of $195M across 3 funding rounds to date. The company's 1st funding round was a Series D of $81M, raised on Jan 2020.

ZAP-X has 1 employees.

The primary company behind ZAP-X, Zap Surgical India Private Limited, reported revenue of ₹3.17 Cr for FY 2025, up 44% year on year.

Developer of gyroscopic radiosurgery platform. The companys flagship product, ZAP-X platform is a self-shielding technology and non-invasive cancer radiotherapy treatment device. It has applications for the treatment of brain and head and neck cancers.

ZAP-X's top competitors include RefleXion and Mevion Medical Systems.

ZAP-X has 9 investors. Key investors include Foxconn Electronics, Varian, Chow Tai Fook Jewellery, Primavera Capital Group, and Hogy Medical.

ZAP-X operates through Zap Surgical India Private Limited.

The legal entities of ZAP-X currently have 2 directors, including Saloni Singh, John Rodenbeck Adler Jr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available